Jan Bogaerts, Methodology Vice Director at EORTC HQ, discusses clinical trial design for rare cancers with Helen Saul
Hear Jan Bogaerts (photo), EORTC Methodology Vice Director, discuss “Clinical [...]
EORTC trial evaluates androgen deprivation therapy for patients with recurrent / metastatic androgen receptor expressing salivary gland cancer
Salivary gland cancers are a rare, less than 5% of [...]
Can abiraterone and radiotherapy improve survival for patients with metastatic prostate cancer treated with ADT?
Today, metastatic prostate cancer is both deadly and incurable, and [...]
Joint ESR/EORTC session at ECR 2015
A joint European Society of Radiology (ESR) and EORTC session [...]
EORTC supports World Cancer Day 2015
Cancer knows no boundaries. It has, or will, affect us [...]
ETOP/EORTC trial to evaluate denosumab for treating patients with advanced non-small cell lung cancer
Lung cancer is currently the main cause of cancer related [...]
EORTC launches LungTech
Image guided stereotactic body radiation therapy for patients with inoperable [...]
EORTC PAMM Group outlines use of pharmacogenetics in cancer treatment and clinical trials
In an article recently published in the European Journal of [...]
EORTC participates in transatlantic intergroup trial on rare tumors
The chance of relapse or recurrence for patients with early-stage, [...]
SPECTAcolor viable next generation multinational cancer clinical trial infrastructure
Over 500 patients in and availability of high quality biological [...]
